Pacific Center for Financial Services’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629 | Hold |
57
| – | – | ﹤0.01% | 433 |
|
|
2025
Q1 | $510 | Hold |
57
| – | – | ﹤0.01% | 442 |
|
|
2024
Q4 | $537 | Hold |
57
| – | – | ﹤0.01% | 443 |
|
|
2024
Q3 | $460 | Hold |
57
| – | – | ﹤0.01% | 440 |
|
|
2024
Q2 | $484 | Hold |
57
| – | – | ﹤0.01% | 437 |
|
|
2024
Q1 | $512 | Hold |
57
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $641 | Hold |
57
| – | – | ﹤0.01% | 370 |
|
|
2023
Q3 | $492 | Hold |
57
| – | – | ﹤0.01% | 388 |
|
|
2023
Q2 | $590 | Hold |
57
| – | – | ﹤0.01% | 378 |
|
|
2023
Q1 | $619 | Buy |
+57
| New | +$619 | ﹤0.01% | 377 |
|
|
2022
Q3 | $1K | Hold |
57
| – | – | ﹤0.01% | 385 |
|
|
2022
Q2 | $1K | Hold |
57
| – | – | ﹤0.01% | 381 |
|
|
2022
Q1 | $1K | Hold |
57
| – | – | ﹤0.01% | 366 |
|
|
2021
Q4 | $1K | Hold |
57
| – | – | ﹤0.01% | 375 |
|
|
2021
Q3 | $0 | Hold |
57
| – | – | ﹤0.01% | 413 |
|
|
2021
Q2 | $1K | Hold |
57
| – | – | ﹤0.01% | 340 |
|
|
2021
Q1 | $1K | Hold |
57
| – | – | ﹤0.01% | 329 |
|
|
2020
Q4 | $1K | Hold |
57
| – | – | ﹤0.01% | 318 |
|
|
2020
Q3 | $1K | Buy |
+57
| New | +$1K | ﹤0.01% | 297 |
|
|
2020
Q2 | – | Sell |
-57
| Closed | -$1K | – | 318 |
|
|
2020
Q1 | $1K | Buy |
+57
| New | +$1K | ﹤0.01% | 281 |
|